Researchers map interactions of 144 active substances to identify drug benefits
The study yielded over one million dose-responsive curves for existing cancer drugs
Read MoreThe study yielded over one million dose-responsive curves for existing cancer drugs
Read MoreThis form of cancer was responsible for 1.9 million diagnosed cases worldwide in 2020
Read MoreCombined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK
Read MoreChildren accounted for the majority of mpox cases and deaths in the DRC since June 2023
Read MoreHeart failure with preserved ejection fraction makes up 50% of all UK heart failure cases
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479